Implementations by Phenotype

Title Phenotype Institution Algorithm Type Total Cases Total Controlssort descending PPV Sensitivity
Sickle Cell Children's Hospital of Wisconsin Implementation Sickle Cell Disease Children's Hospital of Wisconsin Case Only 99% 99%
Vanderbilt Implementation of Heart Failure Heart Failure (HF) with Differentiation between Preserved and Reduced Ejection Fraction Vanderbilt University Case Only
Lipids Implementation - Columbia Lipids Columbia University Case Only
NU BMI for PRS Body Mass Index (BMI) Northwestern University Case, Control
AMI/1st AMI Vanderbilt Implementation Statins and MACE Vanderbilt University Case Only 50 96%
CDiff NU implementation - May 2012 chart review Clostridium Difficile Colitis Northwestern University Case, Control 90%, 95% 95%
NU migraine for eMERGEseq population Migraine Northwestern University Case, Control
Clopidogrel Poor Metabolizers-Columbia Clopidogrel Poor Metabolizers Columbia University Case Only
Harvard Breast Cancer Breast Cancer Case Only
Updated Geisinger Impl CAAD (Carotid Artery Atherosclerosis Disease) Geisinger Case, Control
VUMC Post-event Pain Post-event Pain algorithm VUMC Case Only
GH/UW Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) GH/UW Case Only
DR Marshfield Implementation Diabetic Retinopathy Marshfield Clinic Research Foundation Case, Control 80%, 98% 98%, 86%
Sickle Cell Froedtert Hospital Implementation Sickle Cell Disease Froedtert Hospital Case Only 96% 98%
PAD Marshfield Implementation Peripheral Arterial Disease - 2012 Marshfield Clinic Research Foundation Case Only 88% 97%
Mount Sinai -- BMI Body Mass Index (BMI) Mount Sinai Case Only
Geisinger Implementation Autoimmune Disease Phenotype Geisinger Case, Control
CRS VUMC CRS (Chronic Rhinosinusitis) Vanderbilt University Medical Center Case, Control
Statins and MACE Marshfield Implementation Statins and MACE Marshfield Clinic Research Foundation Case Only 50 100% 100%
Group Health implementation Clostridium Difficile Colitis Group Health Cooperative Case, Control 92%, 88%
VUMC RA Rheumatoid Arthritis (RA) Vanderbilt University Medical Center Case, Control
VUMC ACEi cough implementation ACE Inhibitor (ACE-I) induced cough Vanderbilt University Case, Control 100%, 100% 96%
Validation of ACEi-induced cough algorithm ACE Inhibitor (ACE-I) induced cough Mayo Clinic Case, Control 100%, 96%
Sample Breast Cancer Case Only
CKD for NU WGS subjs Chronic Kidney Disease Northwestern University Case, Control